Everolimus Tablets
Everolimus
Kinase Inhibitor
NADAC/unit
$2.2894
No Shortage
Everolimus Tablets targets specific kinase enzymes involved in cancer cell growth and proliferation.
vs. brand Everolimus: Generic saves up to 77% per unit
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.